Cocaine-Related Disorders Clinical Trial
Official title:
Benefits of Therapy With Virtual Reality Exposure in the Treatment of Cocaine Use Disorders
Cocaine addiction is a multifactorial disease with important consequences: somatic, psychiatric... The number of applications for treatment for cocaine addiction is gradually increasing from year to year but no conventional treatment is available. New tools such as virtual reality could be used in this treatment. We propose to create a virtual reality program based on the analysis of high-risk relapse situations described by patients. We will then assess the effect of this cybertherapy on patients' relapse time and their desire to use cocaine
In France, according to the Health Barometer 2017, cocaine testing has seen two decades of
increases from 1.2% in 1995 to 5.6% in 2017, making it the second most widely used illicit
substance. About 5% of cocaine users may become addicted in the first year of use, while 20%
will develop long-term addiction. This dependence or substance use disorder is characterized
in particular by a loss of control of cocaine use and continued use despite the negative
consequences. Another of the central dimensions of this disorder is the craving (irresistible
or irrepressible need or desire to consume) which is caused by internal or external stimuli.
Craving is the cause of frequent loss of controls and re-consumption.
The treatment of cocaine addictions is generally based on a dual model of pharmacological
treatment often aimed at limiting craving and psychotherapeutic treatment in order to alter
the emotions and memory associated with cocaine use; for example: relearning product
management when it comes to the subject.
In this context, the use of a 3D tool, which allows a gradual and well-detested exposure
without confrontation, seems an interesting prospect. Virtual reality therapies have
historically been known for treating phobias (fears). In addictions, exposure therapies are
done in imagination and rarely with consumer-inducing situations. Since 2000, several
researchers have successfully used virtual reality applications in addictions, but there is
little data on objective assessments of the effectiveness of cybertherapy in the treatment of
cocaine addictions.
All of these elements converge to propose a protocol called "CORVI" to evaluate the
effectiveness of virtual reality exposure therapy as the management of patients with cocaine
use disorder versus management classic.
The project is based on 3 phases: 1/construction of films that can be used in cybertherapy
that reproduce situations in which there are stimuli generating "craving" to cocaine. 2/
Treatment of 2 randomized patient groups with and without cybertherapy (n-20/group) 3/Relapse
evaluations at 1.2 and 3 months post-treatment
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01526538 -
Improving Learning-based Treatment of Cocaine Dependence With Medication
|
Phase 2 | |
Completed |
NCT00877435 -
Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial
|
N/A | |
Completed |
NCT00430690 -
Acoustic Startle Reduction In Cocaine Dependence
|
||
Completed |
NCT00217997 -
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
|
N/A | |
Active, not recruiting |
NCT00094315 -
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
|
Phase 1 | |
Terminated |
NCT00142883 -
The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3
|
N/A | |
Completed |
NCT00218348 -
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
|
Phase 2 | |
Completed |
NCT00158132 -
Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
|
Phase 2 | |
Completed |
NCT00142844 -
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
|
Phase 2 | |
Completed |
NCT00000294 -
Effects of Carvedilol on Cocaine Use in Humans - 11
|
Phase 2 | |
Completed |
NCT00015054 -
Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3
|
Phase 2 | |
Completed |
NCT00000308 -
Dextroamphetamine-Cocaine Behavioral Intervention - 5
|
Phase 2 | |
Completed |
NCT00000281 -
Pharmacotherapy for Schizophrenic Drug Users - 6
|
Phase 2 | |
Terminated |
NCT00000276 -
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
|
Phase 1 | |
Completed |
NCT00000277 -
Mazindol for Cocaine Abuse - 2
|
Phase 2 | |
Completed |
NCT00000280 -
Glutaminergic Agents for Cocaine Abuse - 5
|
Phase 1 | |
Completed |
NCT00000306 -
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
|
Phase 2 | |
Completed |
NCT00000278 -
Disulfiram for Cocaine-Alcohol Abuse - 3
|
Phase 2 | |
Completed |
NCT00000314 -
M-CPP and Fenfluramine in Cocaine Addicts - 3
|
Phase 2 | |
Completed |
NCT00000282 -
Pemoline for Cocaine Abuse - 7
|
Phase 2 |